Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes Observational Study at MHOA
The objectives of this molecular profiling protocol are to describe current treatment patterns and consequences from first-line treatment regimes and subsequent strategies in patients with Classic Hodgkin Lymphoma (cHL), to evaluate clinical outcomes and quality of life, and to characterize tumor and host immunophenotypic/molecular profiles.
This is an observational, non-interventional multi-center phase 4 study that will enroll patients diagnosed and treated for Hodgkin Lymphoma.
MHOA Principle Investigator
Alec Goldenberg, M.D.